Israeli Prime Minister Benjamin Netanyahu voiced his optimism on Monday that the country’s coronavirus crisis could soon be over after drug-maker Moderna announced that testing had shown its SARS-CoV-2 vaccine to be highly effective.

“This is great news for Israel,” said Netanyahu shortly after the announcement. “Already in June I, along with Health Minister Yuli Edelstein, instructed that an agreement be signed with Moderna for the supply of vaccines. Today, Moderna informed us that its vaccine has an efficacy of 94.5 percent.”

Netanyahu said that his goal is “to bring as many vaccines as possible from as many sources as possible to as many citizens as possible—and as soon as possible.”

Moderna’s announcement comes just days after pharmaceutical giant Pfizer declared that its vaccine had an efficacy of more than 90 percent.

Israel signed an agreement with Pfizer last week guaranteeing it will be among the first countries to receive the vaccine once it is developed and approved. Netanyahu said that Pfizer’s vaccine will start arriving in Israel as early as January 2021.

The two vaccines are different in terms of their storage requirements. The Pfizer vials require storage at much colder temperatures, which could complicate their shipment to Israel.

Israel is also casting a wider net in its quest to secure a COVID-19 vaccine, approaching Russia on Monday to discuss buying its Sputnik V vaccine.

“About an hour ago, I spoke with Russian President Vladimir Putin regarding the possibility of purchasing an option on the vaccine Sputnik-V,” Netanyahu told reporters. “We will discuss this in the coming days.”

Russia stated last week that in accordance with interim data during the third stage of clinical trials, the vaccine was effective in 92 percent of cases.

The Kremlin issued a statement saying Putin and Netanyahu had discussed potential cooperation regarding the Russian vaccine, including supplying it to Israel and even producing it in the Jewish state.

Israel is also developing its own vaccine, called BriLife, which could potentially be market-ready by the end of the summer.

Said Netanyahu: “My goal is to bring as many vaccines from as many sources to as many citizens as quickly as possible.”

Support Jewish Journalism
with 2020 Vision

One of the most intriguing stories of the sudden Coronavirus crisis is the role of the internet. With individuals forced into home quarantine, most are turning further online for information, education and social interaction.

JNS's influence and readership are growing exponentially, and our positioning sets us apart. Most Jewish media are advocating increasingly biased progressive political and social agendas. JNS is providing more and more readers with a welcome alternative and an ideological home.

During this crisis, JNS continues working overtime. We are being relied upon to tell the story of this crisis as it affects Israel and the global Jewish community, and explain the extraordinary political developments taking place in parallel.

Our ability to thrive in 2020 and beyond depends on the generosity of committed readers and supporters. Monthly donations in particular go a long way in helping us sustain our operations. We greatly appreciate any contributions you can make during these challenging times. We thank you for your ongoing support and wish you blessings for good health and peace of mind.